ABVACC, Inc.
1Patents
1Active
1Granted
52Portfolio score
Filing activity: Feb 25, 2022 → Feb 25, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11826412B2 | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.